IOBT
Companies
NASDAQ
Io Biotech Inc.
Health Care
$1.30
+$0.38 (+41.30%)
Price Chart
Overview
About IOBT
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Market Cap
$81.2M
Volume
105.0K
Avg. Volume
129.1K
P/E Ratio
-0.8803419
Dividend Yield
0.00%
Employees
61.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.74
Low Correlation
Volatility
High (0.93)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, IOBT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$81.2M
Volume105.0K
P/E Ratio-0.88
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025